Muscarinic acetylcholine receptors: signal transduction through multiple effectors
The DOI matches its Crossref record.
Abstract
Muscarinic receptors regulate a number of important basic physiologic functions including heart rate and motor and sensory control as well as more complex behaviors including arousal, memory, and learning. Loss of muscarinic receptor number or function has been implicated in the etiology of several neurological disorders including Alzheimer's dementia, Down's syndrone, and Parkinson's disease. Muscarinic receptors transduce their signals by coupling with G‐proteins, which then modulate the activity of a number of effector enzymes and ion channels. Five subtypes of muscarinic receptors (m1‐m5) have been identified by molecular cloning and much has been learned about their distribution, pharma‐cology, and structure. Less is known about the molecular mechanisms of receptor‐effector coupling and the biological role of each receptor subtype. The ectopic expression of genes encoding a single muscarinic receptor subtype in mammalian cell lines has provided an important model system in which to investigate receptor subtype‐specific pharmacology and signal transduction. Expression models have revealed that single muscarinic receptor m1, m3, or m5 subtypes can activate multiple signaling effectors simultaneously including phospholipases A2, C, and D, as well as tyrosine kinase and a novel class of voltage‐ insensitive calcium channels. The m2 or m4 receptors have been shown to augment phospholipase A2 in addition to their established role as inhibitory receptors acting through the attenuation of adenylate cyclase. In addition to allowing investigations of the regulatory mechanisms of muscarinic receptors, expression models provide an excellent tool to investigate receptor‐subtype specific physiology and pharmacology.—Felder, C. C. Muscarinic acetylcholine receptors: signal transduction through multiple effectors. FASEB J. 9, 619‐625 (1995)
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Alzheimer's disease: Targeting the Cholinergic System
H. Ferreira-Vieira, T., M. Guimaraes, I., R. Silva, F., & M. Ribeiro, F. (2016) · Current Neuropharmacology · doi:10.2174/1570159x13666150716165726 · Cited by 1,551
International Union of Pharmacology. XVII. Classification of Muscarinic Acetylcholine Receptors
Caulfield, M. P., & Birdsall, N. J. M. (1998) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01362-0 · Cited by 1,474
Nitric Oxide and Cardiac Function
Kelly, R. A., Balligand, J.-L., & Smith, T. W. (1996) · Circulation Research · doi:10.1161/01.res.79.3.363 · Cited by 711
Glial Calcium: Homeostasis and Signaling Function
VERKHRATSKY, A., ORKAND, R. K., & KETTENMANN, H. (1998) · Physiological Reviews · doi:10.1152/physrev.1998.78.1.99 · Cited by 689
Adrenergic and Muscarinic Receptors in the Human Heart
Brodde, O.-E., & Michel, M. C. (1999) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01425-x · Cited by 673
A regenerative approach to the treatment of multiple sclerosis
Deshmukh, V. A., Tardif, V., Lyssiotis, C. A., Green, C. C., Kerman, B., Kim, H. J., Padmanabhan, K., Swoboda, J. G., Ahmad, I., Kondo, T., et al. (2013) · Nature · doi:10.1038/nature12647 · Cited by 531
Mechanisms and Physiological Significance of the Cholinergic Control of Pancreatic β-Cell Function
Gilon, P., & Henquin, J.-C. (2001) · Endocrine Reviews · doi:10.1210/edrv.22.5.0440 · Cited by 508
G protein-coupled receptors (GPCRs): advances in structures, mechanisms and drug discovery
Zhang, M., Chen, T., Lu, X., Lan, X., Chen, Z., & Lu, S. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01803-6 · Cited by 491
Expression and Function of the Cholinergic System in Immune Cells
Fujii, T., Mashimo, M., Moriwaki, Y., Misawa, H., Ono, S., Horiguchi, K., & Kawashima, K. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01085 · Cited by 374
Vizi, E. S. (2000) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01436-4 · Cited by 313
Towards a muscarinic hypothesis of schizophrenia
Raedler, T. J., Bymaster, F. P., Tandon, R., Copolov, D., & Dean, B. (2007) · Molecular Psychiatry · doi:10.1038/sj.mp.4001924 · Cited by 291
Ma, L., Seager, M. A., Wittmann, M., Jacobson, M., Bickel, D., Burno, M., Jones, K., Graufelds, V. K., Xu, G., Pearson, M., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0900903106 · Cited by 285
Muscarinic receptors in the Mammalian Heart
Dhein, S., van Koppen, C. J., & Brodde, O.-E. (2001) · Pharmacological Research · doi:10.1006/phrs.2001.0835 · Cited by 263
Signaling Microdomains Define the Specificity of Receptor-Mediated InsP3 Pathways in Neurons
Delmas, P., Wanaverbecq, N., Abogadie, F. C., Mistry, M., & Brown, D. A. (2002) · Neuron · doi:10.1016/s0896-6273(02)00641-4 · Cited by 256
Molecular Targets for Treating Cognitive Dysfunction in Schizophrenia
Gray, J. A., & Roth, B. L. (2007) · Schizophrenia Bulletin · doi:10.1093/schbul/sbm074 · Cited by 225
Shapiro, M. S., Roche, J. P., Kaftan, E. J., Cruzblanca, H., Mackie, K., & Hille, B. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-05-01710.2000 · Cited by 201
“Although stimulation of M1 receptors in many other cells causes release of Ca 21 from IP3-sensitive stores via the actions of PLC (Felder, 1995), in rat SCG neurons muscarinic agonists do not induce an observable increase in [Ca21]i (Wanke et al., 1987; Beech et al., 1991).”
InfluentialAlpha7 Nicotinic Acetylcholine Receptor Is a Target in Pharmacology and Toxicology
Pohanka, M. (2012) · International Journal of Molecular Sciences · doi:10.3390/ijms13022219 · Cited by 180
“groups: the first was stimulatory, connected with the activity of phospholipase C, the second type is inhibitory based on the suppression of adenylate cyclase activity [16].”
BackgroundProperties of Carbachol-Induced Oscillatory Activity in Rat Hippocampus
Williams, J. H., & Kauer, J. A. (1997) · Journal of Neurophysiology · doi:10.1152/jn.1997.78.5.2631 · Cited by 162
Villard, V., Espallergues, J., Keller, E., Vamvakides, A., & Maurice, T. (2011) · Journal of Psychopharmacology · doi:10.1177/0269881110379286 · Cited by 139
Siwek, M. E., Müller, R., Henseler, C., Trog, A., Lundt, A., Wormuth, C., Broich, K., Ehninger, D., Weiergräber, M., & Papazoglou, A. (2015) · Neural Plasticity · doi:10.1155/2015/781731 · Cited by 71
Shalinsky, M. H., Magistretti, J., Ma, L., & Alonso, A. A. (2002) · Journal of Neurophysiology · doi:10.1152/jn.2002.88.3.1197 · Cited by 65
“…because INCM is known to be activated by muscarinic re- J Neurophysiol • VOL 88 • SEPTEMBER 2002 • www.jn.org by 10.220.33.6 on S eptem ber 8, 2017 http://jn.physiology.org/ D ow nloaded from ceptors of the M1 subtype (Klink and Alonso 1997c) which couple to Gq (Felder 1995; Mullaney et al. 1996).”
BackgroundInfluentialFine Tuning Muscarinic Acetylcholine Receptor Signaling Through Allostery and Bias
van der Westhuizen, E. T., Choy, K. H. C., Valant, C., McKenzie-Nickson, S., Bradley, S. J., Tobin, A. B., Sexton, P. M., & Christopoulos, A. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.606656 · Cited by 63
“These include those linked to phospholipase C (PLC), calcium release, phospholipase D (PLD), phospholipase A2(PLA2), cAMP increases and decreases, and mitogen-activated protein kinase pathways (Felder, 1995; Nathanson, 2000).”
BackgroundMoringa oleifera Seed Extract Alleviates Scopolamine-Induced Learning and Memory Impairment in Mice
Zhou, J., Yang, W.-S., Suo, D.-Q., Li, Y., Peng, L., Xu, L.-X., Zeng, K.-Y., Ren, T., Wang, Y., Zhou, Y., et al. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00389 · Cited by 53
“Because Akt and ERK1/2 are related to learning and memory processes, agents that affect activation of Akt and ERK1/2 may have potential benefits for the treatment of AD.”
BackgroundInfluentialTeber, I., Köhling, R., Speckmann, E.-J., Barnekow, A., & Kremerskothen, J. (2004) · Molecular Brain Research · doi:10.1016/j.molbrainres.2003.11.017 · Cited by 53
Stewart, A. E., Yan, Z., Surmeier, D. J., & Foehring, R. C. (1999) · Journal of Neurophysiology · doi:10.1152/jn.1999.81.1.72 · Cited by 42
Liberto, V., Mudo, G., Fuxe, K., & Belluardo, N. (2014) · Current Protein & Peptide Science · doi:10.2174/1389203715666140901112245 · Cited by 19
Rapoport, S. I., & Hibbeln, J. R. (2020) · Prostaglandins, Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2020.102118 · Cited by 11
Wood, M. W., Segal, J. A., Mark, R. J., Ogden, A. M., & Felder, C. C. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0742033.x · Cited by 11
Self-citation
Metadata
- Authors
- Felder, C. C.
- Venue
- The FASEB Journal
- Publisher
- Wiley
- Published
- 1995-05
- Volume
- 9
- Issue
- 8
- Pages
- 619-625
- ISSN
- 0892-6638 (ISSN-L)
- 1530-6860
- OpenAlex
- W1745534060
- Cited by
- 505
- References
- 0
- FWCI
- 7.22
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.